Novacyt announced that David Allmond is stepping down as Chief Executive Officer (CEO), with immediate effect, to enable him to pursue other business opportunities. James McCarthy, currently the Company's Chief Financial Officer (CFO), will assume the role of Acting CEO until a successor is appointed. Steve Gibson, Group Finance Director, will take on a substantial part of the CFO responsibilities to assist James in this period.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.83 EUR | +10.67% | +39.97% | +16.41% |
Apr. 19 | Novacyt: confident ahead of DHSC trial | CF |
Apr. 19 | Novacyt expects court to dismiss application by UK DHSC | AN |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.41% | 56.42M | |
-28.28% | 905M | |
-21.76% | 130M | |
-18.62% | 59.78M | |
+0.68% | 58.78M | |
-2.40% | 50.16M |
- Stock Market
- Equities
- ALNOV Stock
- News Novacyt
- Novacyt Announces Executive Changes